Medtronic Touts AdaptivCRT Algorithm Economic Benefits With New Heart Failure Data

Results of ADAPTIVE CRT trial show that resynchronization therapy devices with Medtronic's AdaptivCRT algorithm reduce heart failure hospitalizations.

More from Archive

More from Medtech Insight